Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide.
The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals.
Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies.
Visit www.ventana.com to learn more.
|
|
|
|
|
501-1,000 employees
View all Ventana Medical Systems employees
|
|
|
Biotechnology
|
|
|
1910 E. Innovation Park Drive, Tucson, Arizona 85755, US
|
|
|
1985
|
|
|
Companion Diagnostics, Digital Pathology, Image Analysis, Personalized Healthcare, Immunohistochemistry (Ihc), Special Stains, Advanced Workflow, Hematoxylin And Eosin (H&E), In Situ Hybridization (Ish)
|
Bernard Colombo is the CEO of Ventana Medical Systems. To contact Bernard Colombo email at [email protected].
The decision makers in Ventana Medical Systems are Bernard Colombo, John Lubniewski, Katie M Gelacio, etc. Click to Find Ventana Medical Systems decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.